These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 26302879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
    El Nakeeb A, ElGawalby A, A Ali M, Shehta A, Hamed H, El Refea M, Moneer A, Abd El Rafee A.
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD, Paik KY, Park IY, Yoo YK.
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [Abstract] [Full Text] [Related]

  • 4. Prospective randomized trial of the effect of octreotide on pancreatic juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.
    Fernández-Cruz L, Jiménez Chavarría E, Taurà P, Closa D, Boado MA, Ferrer J.
    HPB (Oxford); 2013 May; 15(5):392-9. PubMed ID: 23557411
    [Abstract] [Full Text] [Related]

  • 5. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.
    Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB.
    Ann Surg; 1997 Nov; 226(5):632-41. PubMed ID: 9389397
    [Abstract] [Full Text] [Related]

  • 6. Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.
    Belyaev O, Polle C, Herzog T, Munding J, Chromik AM, Meurer K, Tannapfel A, Bergmann U, Müller CA, Uhl W.
    Scand J Surg; 2013 Nov; 102(3):164-70. PubMed ID: 23963030
    [Abstract] [Full Text] [Related]

  • 7. Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial.
    Andrianello S, Marchegiani G, Malleo G, Masini G, Balduzzi A, Paiella S, Esposito A, Landoni L, Casetti L, Tuveri M, Salvia R, Bassi C.
    JAMA Surg; 2020 Apr 01; 155(4):313-321. PubMed ID: 32101272
    [Abstract] [Full Text] [Related]

  • 8. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
    Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, Campbell KA, Choti MA.
    Ann Surg; 2000 Sep 01; 232(3):419-29. PubMed ID: 10973392
    [Abstract] [Full Text] [Related]

  • 9. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA, Jeanmonod P, Schuld J, Moussavian MR, Schilling MK, Kollmar O.
    Dig Surg; 2012 Sep 01; 29(6):484-91. PubMed ID: 23392293
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
    Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK.
    Eur J Surg Oncol; 2008 Aug 01; 34(8):868-875. PubMed ID: 18299182
    [Abstract] [Full Text] [Related]

  • 11. Prospectively randomized trial using perioperative low dose octreotide to prevent organ related and general complications following pancreatic surgery and pancreatico-jejunostomy.
    Hesse UJ, De Decker C, Houtmeyers P, Demetter P, Ceelen W, Pattyn P, Troisi R, de Hemptinne B.
    Acta Chir Belg; 2005 Aug 01; 105(4):383-7. PubMed ID: 16184721
    [Abstract] [Full Text] [Related]

  • 12. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.
    Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD, Choti MA, Coleman J, Hodgin MB, Sauter PK, Sonnenday CJ, Wolfgang CL, Marohn MR, Yeo CJ.
    J Gastrointest Surg; 2006 Nov 01; 10(9):1280-90; discussion 1290. PubMed ID: 17114014
    [Abstract] [Full Text] [Related]

  • 13. [Impact of octreotide on pancreatic fistula after pancreaticoduodenectomy: a prospective study].
    Kong R, Hu J, Li L, Wang G, Chen H, Bai X, Wang Y, Wu L, Jiang H, Sun B.
    Zhonghua Wai Ke Za Zhi; 2016 Jan 01; 54(1):21-4. PubMed ID: 26792348
    [Abstract] [Full Text] [Related]

  • 14. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA, Johnson LB, Haddad N, Al-Kawas F, Carroll J, Jha R, Wong J, Maglaris D, Mertens S, Fishbein T.
    Am J Surg; 2011 Apr 01; 201(4):481-5. PubMed ID: 21421102
    [Abstract] [Full Text] [Related]

  • 15. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ, López Cillero P, Rufián Peña S, Solórzano Peck G, Miño Fugarolas G, Pera Madrazo C.
    Rev Esp Enferm Dig; 1998 Oct 01; 90(10):687-94. PubMed ID: 9824933
    [Abstract] [Full Text] [Related]

  • 16. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B.
    Clin Transplant; 2005 Jun 01; 19(3):299-303. PubMed ID: 15877788
    [Abstract] [Full Text] [Related]

  • 17. Is constant negative pressure for external drainage of the main pancreatic duct useful in preventing pancreatic fistula following pancreatoduodenectomy?
    Sunagawa M, Yokoyama Y, Yamaguchi J, Ebata T, Sugawara G, Igami T, Mizuno T, Nagino M.
    Pancreatology; 2019 Jun 01; 19(4):602-607. PubMed ID: 30967345
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis.
    Bootsma BT, Plat VD, van de Brug T, Huisman DE, Botti M, van den Boezem PB, Bonsing BA, Bosscha K, Dejong CHC, Groot-Koerkamp B, Hagendoorn J, van der Harst E, de Hingh IH, de Meijer VE, Luyer MD, Nieuwenhuijs VB, Pranger BK, van Santvoort HC, Wijsman JH, Zonderhuis BM, Kazemier G, Besselink MG, Daams F, Dutch Pancreatic Cancer Group.
    Pancreatology; 2022 Apr 01; 22(3):421-426. PubMed ID: 35304104
    [Abstract] [Full Text] [Related]

  • 19. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
    Barnett SP, Hodul PJ, Creech S, Pickleman J, Arahna GV.
    Am Surg; 2004 Mar 01; 70(3):222-6; discussion 227. PubMed ID: 15055845
    [Abstract] [Full Text] [Related]

  • 20. A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.
    McMillan MT, Zureikat AH, Hogg ME, Kowalsky SJ, Zeh HJ, Sprys MH, Vollmer CM.
    JAMA Surg; 2017 Apr 01; 152(4):327-335. PubMed ID: 28030724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.